01/29/2019
Bio-Rad announced the availability of Liquichek Serum Indices that are used as part of laboratory interference testing to monitor an instrument’s ability to detect HIL specimen interferences in patient samples.
01/21/2019
Bio-Rad announced the launch of qUAntify Advance Control for use in clinical labs performing urinalysis testing.
12/06/2018
Bio-Rad announced expanded global access of the company’s quality controls across multiple Abbott clinical diagnostics platforms that now includes the Abbott Alinity ci-series instruments.
10/07/2018
Inpeco and Bio-Rad announced their partnership to connect the Inpeco FlexLab track and the D-100 System to provide high-volume laboratories improved operational efficiencies to meet the growing worldwide demand for diabetes testing.
08/01/2017
Bio-Rad Launches Recombinant Luteinizing Hormone, Expanding its Critical Raw Materials Portfolio
07/28/2017
Bio-Rad Receives FDA Clearance to Aid in Diagnosing Diabetes with its D-10 Hemoglobin A1c Program
07/24/2017
Bio-Rad Signs Agreement with VISIA Imaging for Fully-Automated IFA Slide Processing and Reading System
07/24/2017
Bio-Rad Announces the Addition of Analytes for Liquichek Tumor Marker Control
07/05/2017
The BioPlex 2200 ToRC IgM Assay is a fully automated assay for the detection of IgM class antibodies to Toxoplasma gondii, rubella, and cytomegalovirus (CMV) offered in a multiplexed panel.
05/22/2017
Microsoft operating systems recently experienced a security vulnerability resulting from a widespread ransomware attack through Microsoft’s network environments on a global scale. Bio-Rad’s internal IT team has evaluated the technical details of the Microsoft security update and has approved the patch.